| Original language | English (US) |
|---|---|
| Pages (from-to) | 2306-2307 |
| Number of pages | 2 |
| Journal | Circulation |
| Volume | 138 |
| Issue number | 20 |
| DOIs | |
| State | Published - Nov 13 2018 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Circulation, Vol. 138, No. 20, 13.11.2018, p. 2306-2307.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Response by Kumbhani et al to Letters Regarding Article, "association between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted with Heart Failure
T2 - Insights from Get with the Guidelines-Heart Failure"
AU - Kumbhani, Dharam J
AU - Fonarow, Gregg C.
AU - Heidenreich, Paul A.
AU - Schulte, Phillip J.
AU - Lu, Di
AU - Hernandez, Adrian
AU - Yancy, Clyde
AU - Bhatt, Deepak L.
N1 - Funding Information: Dr Kumbhani has received honoraria from the American College of Cardiology. Dr Fonarow has received research funding from the National Institutes of Health and is a consultant for Amgen, Janssen, Medtronic, Novartis, and St Jude Medical. Dr Bhatt is on the Advisory Board of Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences; is on the Board of Directors of Boston VA Research Institute and the Society of Cardiovascular Patient Care; is a chair of the American Heart Association Quality Oversight Committee; is on the Data Monitoring Committees of the Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, and Population Health Research Institute; has received honoraria from the American College of Cardiology (senior associate editor, Clinical Trials and News, ACC.org), Belvoir Publications (editor-in-chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (editor-in-chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (guest editor, associate editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (chief medical editor, Cardiology Today’s Intervention), Society of Cardiovascular Patient Care (secretary/treasurer), and WebMD (CME steering committees); is a deputy editor of Clinical Cardiology; is Chair of the NCDR-ACTION Registry Steering Committee; is Chair of the VA CART Research and Publications Committee; has received research funding from Amarin, Am-gen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, and the Medicines Company; has received royalties from Elsevier (editor, Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease); is a site coinvestigator for Biotronik, Boston Scientific, and St Jude Medical (now Abbott); is a trustee for American College of Cardiology; and has received unfunded research funding from FlowCo, Merck, PLx Pharma, and Takeda. The other authors declare no conflicts of interest.
PY - 2018/11/13
Y1 - 2018/11/13
UR - http://www.scopus.com/inward/record.url?scp=85058918812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058918812&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.118.036250
DO - 10.1161/CIRCULATIONAHA.118.036250
M3 - Letter
C2 - 30571514
AN - SCOPUS:85058918812
SN - 0009-7322
VL - 138
SP - 2306
EP - 2307
JO - Circulation
JF - Circulation
IS - 20
ER -